Clinical utility of Y-90-DOTA Lanreotide in the treatment of anaplastic or metastatic undifferentiated thyroid carcinoma.

R Moncayo,G Riccabona,M Wenger, I Virgolini, P Angelberger

EUROPEAN JOURNAL OF NUCLEAR MEDICINE(1999)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要